Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Could Push Redhill Rdhl Stock Higher Price At 0.80 Down 1.72 20260402 Ikt Stock Analysis Inhibikase Therapeutics Inc 0.55 Dip At 1.8 Biotech Performance Review 20260403 Why Is Versus Systems Vs Stock Outperforming Recently Price At 1.09 Down 0.91 20260409 Is Metropolitan Mcb Stock Good For Passive Investors Price At 85.78 Up 0.92 20260408 Is Zk Zkin Stock Expanding Price At 1.58 Down 3.66 20260406 MSLE Satellos Bioscience Inc reports far wider than expected Q4 2025 loss while its shares post modest gains amid positive investor sentiment COGT Cogent Biosciences Inc reports wider Q4 2025 loss than consensus analyst estimates with shares dipping 036 percent in todays trading RF RFAM Stock Modified Order Sideways 20260416 Heartcore Enterprises HTCR Market Dynamics Q2 2025 EPS Tops Views How Goldman GSBD margins compare to industry leaders 178 20260511 What PIMCO PDO management focus reveals about priorities Overhead Buying 20260511 KBR KBR Q4 2025 earnings outperform analyst forecasts steady revenue growth drives mild share gains What Nuveen JLS flagged as biggest challenges ahead JLS Earnings Nuveen Mortgage Income Fund Reports No Earnings Data Hinge Health HNGE Stock Why It Matters Today 007 20260422 PLMKU Plum signals confidence in closing a highgrowth tech merger in its latest quarterly earnings update UXIN Uxin shares gain 319 percent following release of its 2025 first quarter earnings update FFIV F5 Q1 2026 EPS beats estimates by 106 percent shares climb 117 percent on solid results SNOA Sonoma Pharmaceuticals reports narrow Q1 2026 EPS miss as shares rise 192 percent on mild positive investor sentiment The supply chain story behind Clorox CLX earnings Q1 2026 Profit Exceeds Views USIran Ceasefire Faces New Strain Amid Ship Seizure and Gulf Tensions Traders Shift Expectations Fed Rate Hike Possible by December After Inflation Surge Amazon Meta and Microsoft Face Growing Local Opposition to AI Data Center Expansion Prudential to Acquire 75 Stake in Bharti Life for 3500 Crore Microsoft Corporation MSFT Delivers Q1 2026 Beat EPS 427 vs 414 Expected Inovio Pharmaceuticals INO Falls 615 Watching 116 Support 20260518 Hewlett HPE Holds 3315 Direction Awaited 20260518 JFrog FROG Q1 2026 Results Top Views on Strong Revenue Calumet CLMT Q1 2026 Disappoints EPS 364 Below 057 Views ArcosDorados ARCO Gained 1252 Can It Break 953 20260520 Acumen Pharmaceuticals ABOS Gains Momentum Support Holds at 237 Resistance at 261 in Focus Iran Reviews US Peace Proposal as Trump Signals Patience for Talks Charter Communications Agrees to Acquire Liberty Broadband in Enhanced Buyout Deal MillionDollar Salaries BillionDollar Stakes The Battle for Top AI Talent Intensifies Kevin Warsh Vows ReformOriented Approach as New Federal Reserve Chair Tesla Stock Forms ThreeWeeksTight Pattern Amid Recovery From Deep Slump Gold Price Outlook Analysts Eye 6000 By 2026 Amid Economic Uncertainty ALGT Q1 2026 Earnings EPS Surpasses Estimates by 1214 Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances Crexendo CXDO Q1 2026 Earnings EPS Surges Past Estimates by 256 Amid Sparse Revenue Disclosure Datadog Q1 2026 Earnings EPS Surges Past Estimates as Strong Profitability Drives Stock Higher TrueBlue Inc Q1 2026 Earnings EPS Surprises Above Estimates Despite Negative Earnings Elutia Inc ELUT Slips 333 as Stock Tests Key Support Levels Kairos Pharma Ltd KAPA Edges Lower as Stock Holds Key Support Zone BioMarin Pharmaceutical BMRN Holds Steady Near Support as Investors Evaluate Pipeline Progress USNA Q1 2026 Earnings Strong EPS Surprise Despite Revenue Uncertainty Camden National Corporation CAC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance WORX Q3 2025 Earnings EPS Loss of 015 Amid Significant Stock Surge AMN Healthcare Q1 2026 Earnings Strong EPS Beat Drives Stock Surge VLYPO Q1 2026 Earnings Preferred Stock Series B Reports EPS Beat Stock Edges Higher CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses